The Minnesota Society of Health-System Pharmacists



2020 Sioux Falls Winter Residents’ CE Seminar II

February 15, 2020

7:45am – 12:30pm CST

The Prairie Center – Presentation and Benedictine Rooms

Avera McKennan Hospital & University Health Center Campus

Sioux Falls, SD

Joint Providers

South Dakota Society of Health-System Pharmacists

South Dakota State University College of Pharmacy & Allied Health Professions

_______________________________________________________________________

The South Dakota State University College of Pharmacy and Allied Health Professions is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Program Identification Numbers are listed below.

________________________________________________________________________

Agenda: Saturday, February 15, 2020

7:45-8:00am Registration / Welcome

8:00-8:30am Bruising, Bleeding, and Hemorrhage…Oh My! Anticoagulation Reversal Management

Bailie Carlson, Pharm.D. (Knowledge-based CPE) #0063-9999-20-008-L01-P .05 CEUs

#0063-9999-20-008-L01-T .05 CEUs

8:30-9:00am Multiple Sclerosis

Kayla Clark, Pharm.D. (Knowledge-based CPE) #0063-9999-20-009-L01-P .05 CEUs

#0063-9999-20-009-L01-T .05 CEUs

9:00-9:30am Chimeric Antigen Receptor T-Cell Therapy

Abe Karimi, Pharm.D. (Knowledge-based CPE) #0063-9999-20-010-L01-P .05 CEUs

#0063-9999-20-010-L01-T .05 CEUs

9:30-10:00am Beating Burnout: Mindfulness-based Practices to Overcome Stress in Pharmacy

Brooke Schotters, Pharm.D. (Knowledge-based CPE) #0063-9999-20-011-L04-P .05 CEUs

#0063-9999-20-011-L04-T .05 CEUs

10:00-10:15am Break

10:15-10:45am Guillain-Barré Syndrome

Justine Wilson, Pharm.D. (Knowledge-based CPE) #0063-9999-20-012-L01-P .05 CEUs

#0063-9999-20-012-L01-T .05 CEUs

10:45-11:15am Factor VIII Concentrates in the Treatment of von Willebrand Disease

Natalie Schulze, Pharm.D. (Knowledge-based CPE) #0063-9999-20-013-L01-P .05 CEUs

#0063-9999-20-013-L01-T .05 CEUs

11:15-11:45am Medication Assisted Treatment for Opioid Use Disorder

Amanda Kuhn, Pharm.D. (Knowledge-based CPE) #0063-9999-20-014-L08-P .05 CEUs

#0063-9999-20-014-L08-T .05 CEUs

11:45am-12:15pm Chemotherapy Overdose

Kaitlyn Bailey, Pharm.D. (Knowledge-based CPE) #0063-9999-20-015-L01-P .05 CEUs

#0063-9999-20-015-L01-T .05 CEUs

12:15-12:30pm Wrap-up / evaluations / CE Credit reconciliation

___________________________________

It is the policy and intent of the South Dakota State University College of Pharmacy and

Allied Health Professions that all continuing education programming present evidence-based information

that is professionally objective and non-commercial / non-promotional.

Target Audience: This program is suitable for pharmacists and pharmacy technicians – hospital, community pharmacy and consulting.

C.E. Registration: Please register by clicking the link provided within the e-mail or posted on . Preregistration is important, since this will allow for handouts to be sent out in advance of the meeting. If prospective attendees have any problem accessing the registration site from work, they should be able to gain access from their home computer.

C.E. Handouts: Handouts / learning assessment will be available electronically for participants.

C.E. Credit: Successful completion of each CE session requires continuous attendance, signing the roster, completion of the CPE Verification Form, and completion of the Evaluation/Learning Assessment form. Credit may be earned for individual sessions. A total of 0.4 CEUs (4.0 contact hours) of continuing pharmacy education credit may be earned at this Residents’ CE seminar.

Pharmacists and Technicians must enter their CPE ID number and their personal MM/DD – on their Verification Forms to facilitate the credit award process. Significant delays in providing this information may jeopardize credit award. Credit upload to participant eProfile accounts will occur within 14 business days.

All participants should subsequently check their NABP accounts to verify appropriate credit award.

__________________________________________________

Faculty Presenters:

Bailie Carlson, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Bruising, Bleeding, and Hemorrhage…Oh My! Anticoagulation Reversal Management”

Pharmacist Learning Objectives: 1. Classify the types of anticoagulant therapies and describe their mechanisms of action; 2. Determine appropriate anticoagulation reversal agent(s) based on anticoagulation with specific agent(s); 3. Evaluate the pros and cons related to specific anticoagulation reversal agents.

Pharmacy Technician Learning Objectives: 1. Explain the mechanisms of action of anticoagulants, and describe the mechanisms by which they can be reversed; 2. Identify the special instructions necessary for storage and preparation of agents used for anticoagulation reversal.

Kayla Clark, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Multiple Sclerosis”

Pharmacist Learning Objectives: 1. Identify current treatment options available based on established guidelines; 2. Describe symptom management as an essential component of comprehensive multiple sclerosis care.

Pharmacy Technician Learning Objectives: 1. Provide brief overview of multiple sclerosis to include: Definition, Development of disease, Risk factors, Signs and symptoms, Types of multiple sclerosis;

2. Describe the stability characteristics and storage requirements of intravenous medications used to treat multiple sclerosis.

Abe Karimi, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Chimeric Antigen Receptor T-Cell Therapy”

Pharmacist Learning Objectives: 1. Describe the evolution of CAR-T Therapy and identify its indication for use; 2. Define CAR-T Therapy and process of treatment; 3. Identify pertinent side effects related to CAR-T Therapy and how to properly treat them.

Pharmacy Technician Learning Objectives: 1. Describe the process of CAR-T Therapy; 2. Differentiate the difference between a conditioning regimen and CAR-T reinfusion; 3. Identify pertinent medications for side effect treatment related to CAR-T therapy.

Brooke Schotters, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Beating Burnout: Mindfulness-based Practices to Overcome Stress in Pharmacy”

Pharmacist Learning Objectives: 1. Describe the current state of burnout among pharmacy professionals; 2. Define mindfulness and describe the National Academy of Medicine’s (NAM) systems-based approach to combat burnout; 3. Apply mindfulness techniques in everyday pharmacy practice to reduce stress and burnout symptoms.

Pharmacy Technician Learning Objectives: 1. Describe the current state of burnout among pharmacy professionals; 2. Define mindfulness and describe the National Academy of Medicine’s (NAM) systems-based approach to combat burnout; 3. Apply mindfulness techniques in everyday pharmacy practice to reduce stress and burnout symptoms.

Justine Wilson, Pharm.D. PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Guillain-Barré Syndrome”

Pharmacist Learning Objectives: 1. Identify the most common organisms associated with Guillain-Barré Syndrome; 2. Determine the timeline of progression of Guillain-Barré Syndrome?

Pharmacy Technician Learning Objectives: 1. Identify medication compliance factors and follow up time periods for medication adjustments; 2. Identify medications that could contribute to decreased absorption of levothyroxine; 3. Explain proper storage of levothyroxine medication, and explain the differences between brand name products and generics.

Natalie Schulze, Pharm.D., PGY2 Oncology Pharmacy Resident, Avera Cancer Institute, Sioux Falls, SD

“Factor VIII Concentrates in the Treatment of von Willebrand Disease”

Pharmacist Learning Objectives: 1. Summarize current concepts in the dosing and monitoring of factor VIII concentrates; 2. Highlight the treatment considerations for planned surgeries regarding the use of factor VIII concentrates in von Willebrand disease; 3. Describe treatment considerations for factor VIII concentrates in the setting of bleeding in von Willebrand disease.

Pharmacy Technician Learning Objectives: 1. Explain the appropriate dosing and administration of factor VIII concentrates; 2. Identify common indications for the use of factor VIII concentrates.

Amanda Kuhn, Pharm.D., PGY1 Pharmacy Practice Resident, Avera McKennan Hospital & University Health Center, Sioux Falls, SD

“Medication Assisted Treatment for Opioid Use Disorder”

Pharmacist Learning Objectives: 1. Define medication assisted therapy and the impact it can have on patients with opioid use disorder; 2. Identify monitoring parameters and required labs for medications used for opioid use disorder; 3. Design an appropriate maintenance treatment plan for a patient with opioid use disorder.

Pharmacy Technician Learning Objectives: 1. Identify names of prescription medications and dosage forms utilized for opioid use disorder; 2. List signs and symptoms of withdrawal and classify according to the Clinical Opioid Withdrawal Scale; 3. Describe local resources available for persons with opioid use disorder.

Kaitlyn Bailey, Pharm.D., PGY2 Oncology Pharmacy Resident, Avera Cancer Institute, Sioux Falls, SD

“Chemotherapy Overdose”

Pharmacist Learning Objectives: 1. Assess appropriate utilization of reversal agents for chemotherapy over-

exposure; 2. Describe how medications can be used to manage toxicities related to chemotherapy overexposure.

Pharmacy Technician Learning Objectives: 1. Identify potential compounding errors associated with hazardous medications; 2. Describe potential long-term harm caused by chemotherapy overexposure.

…………………………………

CE Presenters have been mentored by the following residency directors:

Glenn Voss, Pharm.D. - Avera McKennan Hospital & University Health Center PGY1

Bradley Beck Pharm.D., BCOP – Avera Cancer Institute Oncology Pharmacy PGY2

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download